- decreased circulating HDL cholesterol level / IMPC
- abnormal tibia morphology / IMPC
- increased circulating chloride level / IMPC
- increased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- decreased circulating glucose level / IMPC
- increased blood urea nitrogen level / IMPC
- increased circulating sodium level / IMPC
- increased circulating amylase level / IMPC
- decreased mean platelet volume / IMPC
- decreased total body fat amount / IMPC
- increased bone mineral content / IMPC
- decreased fasting circulating glucose level / IMPC
C57BL/6N-Atm1Brd Cbx6tm1a(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:06102 |
Citation information | RRID:IMSR_EM:06102 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Atm1Brd Cbx6tm1a(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | EPD0445_7_A03 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cbx6tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Cbx6 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0445_7_A03. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating chloride level / IMPC
- increased bone mineral content / IMPC
- abnormal tibia morphology / IMPC
- increased circulating sodium level / IMPC
- decreased fasting circulating glucose level / IMPC
- increased circulating amylase level / IMPC
- increased lean body mass / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- increased blood urea nitrogen level / IMPC
- decreased mean platelet volume / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating glucose level / IMPC
- decreased total body fat amount / IMPC
MGI phenotypes (allele matching)
- decreased body weight / MGI
- abnormal bile duct morphology / MGI
- abnormal Mullerian duct morphology / MGI
- abnormal liver vasculature morphology / MGI
- perimembraneous ventricular septal defect / MGI
- absent hypoglossal nerve / MGI
- abnormal Mullerian duct topology / MGI
- abnormal infrahyoid muscle connection / MGI
- blood in lymph vessels / MGI
- abnormal vitelline vein topology / MGI
- abnormal vertebral artery topology / MGI
- heterochrony / MGI
MGI phenotypes (gene matching)
- decreased body weight / MGI
- no abnormal phenotype detected / MGI
- abnormal bile duct morphology / MGI
- abnormal Mullerian duct morphology / MGI
- abnormal liver vasculature morphology / MGI
- perimembraneous ventricular septal defect / MGI
- absent hypoglossal nerve / MGI
- abnormal Mullerian duct topology / MGI
- abnormal infrahyoid muscle connection / MGI
- blood in lymph vessels / MGI
- abnormal vitelline vein topology / MGI
- abnormal vertebral artery topology / MGI
- heterochrony / MGI
- hemangioma / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).